Inventor
VANOTTI ERMES
IT27 patents
⚠️ This page may combine multiple inventors who share the name “VANOTTI ERMES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NERVIANO MEDICAL SCIENCES SRL
8 patentsUS9102662B2Aug 11, 2015
Substituted indazole derivatives active as kinase inhibitors
NERVIANO MEDICAL SCIENCES SRL13 citations92
US10081622B2Sep 25, 2018
Substituted indazole derivatives active as kinase inhibitors
NERVIANO MEDICAL SCIENCES SRL4 citations84
US9616059B2Apr 11, 2017
Substituted indazole derivatives active as kinase inhibitors
NERVIANO MEDICAL SCIENCES SRL6 citations84
US9255087B2Feb 9, 2016
Substituted indazole derivatives active as kinase inhibitors
NERVIANO MEDICAL SCIENCES SRL5 citations84
US9085558B2Jul 21, 2015
Substituted indazole derivatives active as kinase inhibitors
NERVIANO MEDICAL SCIENCES SRL4 citations84
US7618982B2Nov 17, 2009
Heteroarylpyrrolopyridinones active as kinase inhibitors
NERVIANO MEDICAL SCIENCES SRL8 citations82
US9056854B2Jun 16, 2015
Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
NERVIANO MEDICAL SCIENCES SRL2 citations61
US9670191B2Jun 6, 2017
Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
NERVIANO MEDICAL SCIENCES SRL0 citations51
VANOTTI ERMES
4 patentsUS8263604B2Sep 11, 2012
Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
VANOTTI ERMES5 citations71
US8906934B2Dec 9, 2014
Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene-and furane-derivatives as kinase inhibitors
VANOTTI ERMES2 citations60
US8207180B2Jun 26, 2012
Tricyclic indoles and (4,5-dihydro) indoles
VANOTTI ERMES2 citations60
US8293762B2Oct 23, 2012
Isoquinolinopyrrolopyridinones active as kinase inhibitors
VANOTTI ERMES0 citations40